MBMichael R. Boarder

Michael R. Boarder

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael R. Boarder has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Gillian C Bennett

    Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA 94304, USA

    2 shared publications
  • Pamela J. White

    Cell Signaling Laboratory, School of Pharmacy, De Montfort University, The Hawthorn Building, Leicester LE1 9BH, England

    2 shared publications
  • Tania E. Webb

    Cell Signalling Laboratory, School of Pharmacy, De Montfort University, Leicester, United Kingdom

    2 shared publications
  • Anthony P D W Ford

    11Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA 94304, U.S.A.

    1 shared publication
  • Caroline J Emmett

    11Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA 94304, U.S.A.

    1 shared publication
  • Gareth Goh

    11Cell Signalling Laboratory, Leicester School of Pharmacy, De Montfort University, The Hawthorn Building, The Gateway, Leicester LE1 9BH

    1 shared publication

Latest Publications

  • Open Access

    Tangeretin and its metabolite 4′‐hydroxytetramethoxyflavone attenuate EGF‐stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K

    by Z Cheng, S Surichan, K Ruparelia, R Arroo, M R Boarder

    BACKGROUND AND PURPOSE The mechanisms by which the dietary compound tangeretin has anticancer effects may include acting as a prodrug, forming an antiproliferative product in cancer cells. Here we show that tangeretin also inhibits cell cycle progression in hepatocytes and investigate the role of its primary metabolite 4′‐hydroxy‐5,6,7,8‐tetramethoxyflavone (4′‐OH‐TMF) in this effect.EXPERIMENTAL APPROACH We used epidermal growth factor (EGF)‐stimulated rat hepatocytes, with [3H]‐thymidine incorporation into DNA as an index of progression to S‐phase of the cell cycle, and Western blots for phospho‐proteins involved in the cell signalling cascade.KEY RESULTS Incubation of tangeretin with microsomes expressing CYP1A, or with hepatocytes, generated a primary product we identified as 4′‐OH‐TMF. Low micromolar concentrations of tangeretin or 4′‐OH‐TMF gave a concentration‐dependent inhibition of EGF‐stimulated progression to S‐phase while having little effect on cell viability. To determine whether time for conversion of tangeretin to an active metabolite would enhance the inhibitory effect we used long pre‐incubations; this reduced the inhibitory effect, in parallel with a reduction in the concentration of tangeretin. The EGF‐stimulation of hepatocyte cell cycle progression requires signalling through Akt/mTOR/p70S6K kinase cascades. The tangeretin metabolite 4′‐OH‐TMF selectively inhibited S6K phosphorylation in the absence of significant inhibition of upstream Akt activity, suggesting an effect at the level of mTOR.CONCLUSIONS AND IMPLICATIONS Tangeretin and 4′‐OH‐TMF both inhibit cell cycle progression in primary hepatocytes. The inhibition of p70S6K phosphorylation by 4′‐OH‐TMF raises the possibility that inhibition of the mTOR pathway may contribute to the anticancer influence of a flavonoid‐rich diet.


  • ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors

    by Rajendra Kumari, Gareth Goh, Leong L Ng, Michael R Boarder

    It has previously been shown that ATP and UTP stimulate P2Y receptors in vascular smooth muscle cells (VSMCs), but the nature of these receptors, in particular the contribution of P2Y2 and P2Y4 subtypes, has not been firmly established. Here we undertake a further pharmacological analysis of [3H]inositol polyphosphate responses to nucleotides in cultured rat VSMCs. ATP generated a response that was partial compared to UTP, as reported earlier. In the presence of a creatine phosphokinase (CPK) system for regenerating nucleoside triphosphates, the response to ATP was increased, the response to UTP was unchanged, and the difference between UTP and ATP concentration–response curves disappeared. Chromatographic analysis showed that ATP was degraded slightly faster than UTP. The response to UDP was always smaller than that to UTP, but with a shallow slope and a high potency component. In the presence of hexokinase (which prevents the accumulation of ATP/UTP from ADP/UDP), the maximum response to UDP was reduced and the high‐potency component of the curve was retained. By contrast, the response to ADP was weaker throughout in the presence of hexokinase. ATPγS was an effective agonist with a similar EC50 to UTP, but with a lower maximum. ITP was a weak agonist compared with UTP. Suramin was an effective antagonist of the response to UTP (pA2=4.48), but not when ATP was the agonist. However, suramin was an effective antagonist (pA2=4.45) when stimulation with ATP was in the presence of the CPK regenerating system. Taken together with the results of others, these findings indicate that the response of cultured rat VSMCs to UTP and to ATP is predominantly at the P2Y2 receptor, and that there is also a response to UDP at the P2Y6 receptor. British Journal of Pharmacology (2003) 140, 1169–1176. doi:10.1038/sj.bjp.0705526


  • Characterization of a Ca2+ Response to Both UTP and ATP at Human P2Y11 Receptors: Evidence for Agonist-Specific Signaling

    by Pamela J. White, Tania E. Webb, Michael R. Boarder

    Previous reports on heterologously-expressed human P2Y11 receptors have indicated that ATP, but not UTP, is an agonist stimulating both phosphoinositidase C and adenylyl cyclase. Consistent with these findings, we report that in 1321N1 cells expressing human P2Y11 receptors, UTP stimulation did not lead to accumulation of inositol(poly)phosphates under conditions in which ATP gave a robust, concentration-dependent effect. Unexpectedly, however, both UTP and ATP stimulated increases in cytosolic Ca2+ concentration ([Ca2+]c), with both nucleotides achieving similar EC50 and maximal responses. The responses to maximally effective concentrations of ATP and UTP were not additive. The [Ca2+]c increase in response to UTP was less dependent on extracellular Ca2+ than was the response to ATP. AR-C67085 (2-propylthio-β,γ-difluoromethylene-d-ATP, a P2Y11-selective agonist), adenosine 5′-O-(3-thiotriphosphate), and benzoyl ATP were all full agonists with potencies similar to those of ATP and UTP. In desensitization experiments, exposure to ATP resulted in loss of the UTP response; this response was more sensitive to desensitization than that of ATP. Pertussis toxin pretreatment attenuated the response to UTP but left the ATP response unaffected. The presence of 2-aminoethyl diphenylborate differentially affected the responses of ATP and UTP. No mRNA transcripts for P2Y2 or P2Y4 were detectable in the P2Y11-expressing cells. We conclude that UTP is a Ca2+-mobilizing agonist at P2Y11 receptors and that ATP and UTP acting at the same receptor recruit distinct signaling pathways. This example of agonist-specific signaling is discussed in terms of agonist trafficking and differential signal strength.


  • Open Access

    P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia

    by Gillian C Bennett, Anthony P D W Ford, Jacqueline A M Smith, Caroline J Emmett, Tania E Webb, Michael R Boarder

    We have investigated increases in cytosolic Ca2+ in response to nucleotides in mixed rat cerebrocortical cultures (neurons and glia in similar numbers) and in essentially neuron‐free glial cultures. In both cultures, the agonist‐response profile was 2‐methylthioADP(2MeSADP)>2‐methylthioATP(2MeSATP)>ADP>ATP>adenosine 5′‐O‐(3‐thiotriphosphate), consistent with a P2Y1 receptor. The maximal responses to 2MeSADP, 2MeSATP and ADP were identical, but that to ATP was higher. Suramin, pyridoxal‐phosphate‐6‐azophenyl‐2′,4′‐disulphonic acid, reactive blue 2 (RB2), and adenosine biphosphate (A3P5P) were antagonists with apparent pA2 values of 5.5 for suramin, 6.4 for RB2, and 4.7 for A3P5P. Single cell imaging divided the cells from the mixed neuronal–glial cultures into two populations: responsive (neurons) and unresponsive (glial cells) to high [K+]. The response of cells to nucleotides was almost exclusively limited to those not responsive to high K+. In the presence of extracellular Mn2+, the response of the mixed cultures to 30 mM K+ and 20 μM Bay K 8644 was attenuated. However, when 2MeSADP was added there was no reduction in response in cultures previously loaded with Mn2+. This further indicated that the 2MeSADP response was not in the neurons. Reverse transcriptase–polymerase chain reaction studies detected transcripts for P2Y1, P2Y4 and P2Y6 in RNA preparations from embryonic rat cortex, and from both mixed and glial cultures. P2Y2 transcripts were not detected in the embryonic cortex. Based on this and previous work, it is proposed that the principal P2Y influences in the brain are on cytosolic Ca2+ in glial cells and presynaptic sites on neurons. British Journal of Pharmacology (2003) 139, 279–288. doi:10.1038/sj.bjp.0705242


  • Regulation of vascular endothelial cells and vascular smooth muscle cells by multiple P2Y receptor subtypes

    by Michael R. Boarder, Pamela J. White, Jonathon R. Roberts, Tania E. Webb


  • The effect of nucleotides and adenosine on stimulus‐evoked glutamate release from rat brain cortical slices

    by Gillian C Bennett, Michael R Boarder

    Evidence has previously been presented that P1 receptors for adenosine, and P2 receptors for nucleotides such as ATP, regulate stimulus‐evoked release of biogenic amines from nerve terminals in the brain. Here we investigated whether adenosine and nucleotides exert presynaptic control over depolarisation‐elicited glutamate release. Slices of rat brain cortex were perfused and stimulated with pulses of 46 mM K+ in the presence of the glutamate uptake inhibitor L‐trans‐pyrrolidine‐2,4‐dicarboxylic acid (0.2 mM). High K+ substantially increased efflux of glutamate from the slices. Basal glutamate release was unchanged by the presence of nucleotides or adenosine at concentrations of 300 μM. Adenosine, ATP, ADP and adenosine 5′‐O‐(3‐thiotriphoshate) at 300 μM attenuated depolarisation‐evoked release of glutamate. However UTP, 2‐methylthio ATP, 2‐methylthio ADP, and α,β‐methylene ATP at 300 μM had no effect on stimulated glutamate efflux. Adenosine deaminase blocked the effect of adenosine, but left the response to ATP unchanged. The A1 antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine antagonised the inhibitory effect of both adenosine and ATP. Cibacron blue 3GA inhibited stimulus‐evoked glutamate release when applied alone. When cibacron blue 3GA was present with ATP, stimulus‐evoked glutamate release was almost eliminated. However, this P2 antagonist had no effect on the inhibition by adenosine. These results show that the release of glutamate from depolarised nerve terminals of the rat cerebral cortex is inhibited by adenosine and ATP. ATP appears to act directly and not through conversion to adenosine. British Journal of Pharmacology (2000) 131, 617–623; doi:10.1038/sj.bjp.0703598